CC: Q3 EBITDA reached $200M as TT pricing and APM growth offset seasonal TSS weakness

What happened

Third-quarter sales rose 3% from a year earlier and Adjusted EBITDA reached $200M. The company said TT pricing and APM demand offset TSS softness. Full-year EBITDA guidance is $775M–$800M.

Confirmed

Global impact / market context

Management expects earnings growth in 2027 even with uncertain macroeconomic conditions. Profit is still expected to expand despite softer TSS results, so pricing power in TT and demand for APM are carrying overall earnings and shaping capital spending and cash available.

Confirmed

A company growing sales modestly but holding profit near guided levels suggests pricing and product mix are doing more work than volume. That matters for chemical sector peers, because weak TSS demand can pull down plant usage and raise unit costs even when other units grow.

Analyst inference

What to watch

1. Full-year EBITDA guidance of $775M–$800M implies fourth-quarter results must land within that range. Watch whether TT pricing and APM demand stay strong enough to offset TSS softness. Confirmed
2. Track quarterly TSS volume and pricing disclosures to see whether softness deepens. A wider decline would pressure plant utilization, unit costs, and the earnings base used for 2027 growth. Proposed
3. Watch whether management reaffirms 2027 earnings growth while calling macro conditions uncertain. Repeated caveats without revised targets would suggest cost cuts and pricing, not volume, are supporting the profit outlook. Analyst inference

Evidence

• Original source link unavailable